Early detection of peripheral neuropathy in patients with diabetes mellitus type 2

Table 1 Age and clinical characteristics of the studied groups

Variable	Group	Mean ± SD	F	p
Age	Group 1	55.00 ± 6.22	0.249	0.780	P1	0.613
	Group 2	54.10 ± 4.71			P2	0.866
	Group 3	55.30 ± 5.75			P3	0.500
Disease duration (years)	Group 1	3.30 ± 1.30	28.729	0.001*	P1	0.012*
	Group 2	6.60 ± 1.39			P2	0.001*
	Group 3	12.75 ± 6.66			P3	0.001*
HBA1c	Group 1	6.07 ± 0.13	158.127	0.001*	P1	0.001*
	Group 2	7.70 ± 0.49			P2	0.001*
	Group 3	9.11 ± 0.79			P3	0.001*
BMI	Group 1	22.37 ± 1.82	42.797	0.001*	P1	0.001*
	Group 2	24.97 ± 2.41			P2	0.001*
	Group 3	29.01 ± 2.57			P3	0.001*
Diastolic blood pressure	Group 1	77.00 ± 7.33	10.095	0.001*	P1	0.037*
	Group 2	82.00 ± 7.68			P2	0.001*
	Group 3	87.50 ± 7.16			P3	0.022*
Systolic blood pressure	Group 1	125.00 ± 11.12	5.278	0.008*	P1	0.021*
	Group 2	127.50 ± 15.85			P2	0.004*
	Group 3	140.25 ± 19.63			P3	0.014*
Total cholesterol (mg/dl)	Group 1	186.42 ± 12.83	16.250	0.001*	P1	0.021*
	Group 2	196.41 ± 6.39			P2	0.001*
	Group 3	210.27 ± 18.00			P3	0.001*

BMI body mass index, P1 post hoc significance between group 1 and 2, P2 post hoc significance between group 1 and 3, P3 post hoc significance between group 2 and 3
* means statistically significant